Dr. Bukavina and Dr. Dubin on academic urology programs’ evolving use of Twitter
Laura Bukavina, MD, MPH, and Justin Dubin, MD, also discuss their own usage of social media and share advice for medical professionals using social media.
In this video, Laura Bukavina, MD, MPH, and Justin Dubin, MD, discuss the recent European Urology paper, “Growth of the Twitter Presence of Academic Urology Training Programs and Its Catalysis by the COVID-19 Pandemic,” for which they served as study authors. Bukavina is a chief resident in urology at Case Western Reserve University/University Hospitals Cleveland Medical Center, and Dubin is a urology resident at the University of Miami Miller School of Medicine.
Dr. Lacouture on managing dermatological adverse events with apalutamide in prostate cancer
February 7th 2022To investigate the severity and prevalence of dermatologic adverse events associated with apalutamide, Mario E. Lacouture, MD, and investigators conducted a study that will help to manage and counsel patients with prostate cancer in the future, especially with the expanded approval of apalutamide in this space.
How appropriate use criteria for PSMA-PET imaging optimize patient care
February 2nd 2022In a recent interview, Hossein Jadvar, MD, PhD, discussed what the appropriate use criteria consist of for prostate-specific membrane antigen (PSMA)-PET imaging, and why these criteria are vital in ensuring the individualized care of patients.
Dr. Padmanabhan discusses impact of COVID-19
June 11th 2020Urology Times® Editorial Council Member Priya Padmanabhan, MD, MPH, professor of urology at Oakland University William Beaumont School of Medicine, Royal Oak, Michigan, discusses how she has been affected by the coronavirus disease 2019 (COVID-19) pandemic.
